Cite
HARVARD Citation
Nagasawa, M. et al. (n.d.). 171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer. Journal for immunotherapy of cancer. p. A185. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nagasawa, M. et al. (n.d.). 171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer. Journal for immunotherapy of cancer. p. A185. [Online].